FOXO Technologies Inc. (NYSEAMERICAN:FOXO) Short Interest Down 49.2% in March

FOXO Technologies Inc. (NYSEAMERICAN:FOXO) was the recipient of a large decrease in short interest in March. As of March 15th, there was short interest totalling 960,200 shares, a decrease of 49.2% from the February 28th total of 1,890,000 shares. Based on an average daily volume of 7,110,000 shares, the short-interest ratio is presently 0.1 days. Approximately 3.3% of the company’s stock are short sold.

Hedge Funds Weigh In On FOXO Technologies

A hedge fund recently bought a new stake in FOXO Technologies stock. Jane Street Group LLC bought a new stake in shares of FOXO Technologies Inc. (NYSEAMERICAN:FOXO) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 117,047 shares of the company’s stock, valued at approximately $34,000. Jane Street Group LLC owned 0.67% of FOXO Technologies at the end of the most recent quarter. 44.89% of the stock is owned by institutional investors and hedge funds.

FOXO Technologies Stock Performance

Shares of FOXO Technologies stock traded down $0.02 during trading on Friday, reaching $0.12. The company had a trading volume of 1,685,482 shares, compared to its average volume of 14,679,984. FOXO Technologies has a fifty-two week low of $0.12 and a fifty-two week high of $1.30. The firm’s fifty day simple moving average is $0.27.

FOXO Technologies Company Profile

FOXO Technologies Inc engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging.